Development of a new non-hormonal contraceptive targeting the AMH/AMHR2 axis in females.

Speaker: Dr. David Pépin, Harvard Medical School

Title: Development of a new non-hormonal contraceptive targeting the AMH/AMHR2 axis in females.

Description: Anti-Müllerian hormone (AMH) is a paracrine factor produced by growing follicles that mediates negative feedback on the activation and growth of new pre-antral follicles. Sustained supraphysiological AMH can suppress follicular development and induce contraception. Herein we will present findings on the mechanism of action of AMH in follicles, the development of new contraceptive modalities including gene therapy with AMH and small molecule agonists of the AMH receptor (AMHR2), and their evaluation in several animal models from mice to cats.

New Non-hormonal Contraceptive Targets

These webinars, sponsored by the Society for the Study of Reproduction (SSR), Frontiers in Reproduction (FIR), and the Bill & Melinda Gates Foundation, will focus on emerging technologies and approaches to male and female contraception.

Speakers:

Dr. Lonny R. Levin, Professor of Pharmacology, Weill Cornell Medical College

Read more about Dr. Levin’s Presentation

Title: On-demand nonhormonal male contraception via ADCY10 inhibition

Description: Fast-acting sAC inhibitors with slow off-rates can provide safe, pre-coital, on-demand contraception for men which is nonhormonal, orally available, easily tolerated, fast-acting, and readily reversible.

Dr. Celia Santi, Associate Professor of OBGYN, Washington University School of Medicine in St. Louis

Read more about Dr. Santi’s presentation!

Title: Targeting the sperm-specific K+ channel SLO3 for non-hormonal contraception.


Description: Identification of inhibitors of the sperm specific SLO3 K+ channel that can be developed into a non-hormonal class of female contraceptives that act by targeting sperm capacitation.

Developing New Methods for Testing, Studying, and Delivering Contraception

These webinars, sponsored by the Society for the Study of Reproduction (SSR), Frontiers in Reproduction (FIR), and the Bill & Melinda Gates Foundation, will focus on emerging technologies and approaches to male and female contraception.

Speakers:

Dr. Jianjun Sun, Associate Professor, Department of Physiology & Neurobiology, University of Connecticut, Storrs

Read more about Dr. Sun’s Presentation

Title: Screening female contraceptive compounds using Drosophila ovulation model

Description: In my presentation, I will introduce the ovulation mechanism in Drosophila and describe the platform utilizing Drosophila ovulation to screen contraceptive compounds that can effectively inhibit follicle rupture.

Dr. Phil Santangelo, Associate Professor of Biomedical Engineering, Georgia Tech University & Emory University

santangelo.png

Read more about Dr. Santangelo’s Presentation

Title: Intravaginal delivery of mRNA encoded contraceptive antibodies

Back to top